The COVID-19 pandemic has taken millions of lives globally due to the lack of a vaccine against this deadly virus. Many COVID-19 vaccines have been developed to stop the pandemic, but none have yet received WHO EUL/PQ authorization. An effective and reliable vaccine against COVID-19 (coronavirus vaccine) should be capable of providing acquired immunity against the coronavirus disease without any major side effects. Once a potential, safe, and efficacious vaccine for covid 19 is developed, it should be provided equitable access to people around the world who need it.
Know anyone building innovative solutions that belong in this 'Coronavirus Vaccine'?
Magnus Group is extending a cordial invitation for your attendance at the prestigious "5th Edition of World Congress on Infectious Diseases" (WCID 2023), scheduled for October 23-25, 2023, in the magnificent city of Boston, Massachusetts, USA. For those unable to attend in person, virtual attendance options will also be available.
The theme of WCID 2023 is "Promulgating innovations in Infectious Diseases," and the congress will cover all topics related to infectious diseases. The event aims to bring together researchers, scientists, academicians, healthcare professionals, public healthcare experts, infection specialists, and other field experts.
Over three days, attendees will have access to keynote speakers, panel sessions with invited speakers, seminars, oral and poster presentations, as well as a variety of scientific and public health exhibitors, all centred around emerging and re-emerging infectious diseases. The focus of WCID 2023 will be on recent developments and changes in the field of infectious disease, as well as effective measures for controlling the spread of these infections, with a view towards public healthcare. Read on magnusgroup.org
October 23 to October 25, 2023
Hilton Boston/Woburn,2 Forbes Road, Woburn, Massachusetts, 01801, USA
2023 International Conference on Latest Research on Corona Virus and its Vaccine (ICRCVV -2023) will be held in New York, United States of America during 01st - 02nd Sep 2023. ICRCVV-2023 .COVID-19 has speedily spread around the globe, posing enormous health, economic, environmental and social challenges to the entire humanity by severely disrupting the global economy. All human population and nations are struggling to slow down the transmission of the disease by testing & treating patients, quarantining suspected persons through contact tracing, restricting large gatherings, maintaining complete or partial lock down etc. This conference aims to contribute to illustrate the impact of COVID-19 on whole society and global environment, and the possible ways in which the disease can be controlled and solved. Corona Virus and Vaccines Conferences brings together Vaccines scientists from industry, academia, and regulatory agencies along with business delegates to discuss recent developments and future trends in the field of Vaccines process development and production. This conference aims to solve the most critical problems relating to the health and wellbeing of humanity.
The COVID-19 vaccine rollout has created a newfound sense of hope for healthcare organizations, along with an increased sense of urgency to have a strong vaccine management program. As new drugs become available, healthcare and life sciences organizations must ensure efficient distribution and management to scale across the healthcare ecosystem.
During this webinar, you’ll hear from physician leaders at UMass Memorial Medical Center and Tableau as they share how data can simplify all aspects of vaccine planning, including immunization schedules, adequate dose management, patient prioritization, and equitable distribution. They'll also share how vaccine management is progressing and how analytics can achieve the insights necessary to manage the challenges ahead.
The COVID-19 vaccine deployment is well underway. Health systems have experienced both successes and unexpected challenges. Let’s step back and take a pulse check on the healthcare community and review the lessons we have learned.
The vaccine previously known as COVID-19 Vaccine AstraZeneca is now called Vaxzevria according to the European Medicine Agency's (EMA) website. The Sweden National Food Agency has noted that only the …
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our